A Study of IBI3032 in Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

ICON Clinical Research, Lenexa, Kansas, United States
Contact: Study coordinator (Seth Price) · Seth.Price@iconplc.com · 913-205-4397

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Baltimore, United States

A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

C3 Glomerulopathy (C3G) · Healthy Adult Participants

Abroad (travel likely)RecruitingPHASE1

Vienna, Austria · Brussels, Belgium

First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Lincoln, United States

Safety and Pharmacokinetics of Y-4 Tablets in Healthy Subjects

Healthy Adult Male and Female Volunteers

Abroad (travel likely)RecruitingPHASE1

Beijing, China